QIAseq Targeted RNA Panels


Configure at GeneGlobe
Find or custom design the right target-specific assays and panels to research your biological targets of interest.
QIAseq Targeted RNA Panel (12)

Cat. No. / ID:  333002

Kit containing wet bench-verified assays and reagents for first strand synthesis, molecular barcoding, gene-specific amplification and library preparation for targeted RNA sequencing
Copy order details
Configure at GeneGlobe To see pricing
QIAseq Targeted RNA Panel
QIAseq Targeted RNA 12-Index
QIAseq Targeted RNA 96-Index
QIAseq Targeted RNA Panel (12)は分子生物学的アプリケーション用であり、疾病の診断、予防、あるいは治療に使用することはできません。
QIAseq Targeted RNA Panelsは分子生物学的アプリケーション用であり、疾病の診断、予防、あるいは治療に使用することはできません。
Configure at GeneGlobe
Find or custom design the right target-specific assays and panels to research your biological targets of interest.


  • 分子バーコードでPCR duplicate および増幅バイアスを除去
  • わずか25 ng のトータルRNA からスタート
  • シンプルかつ1日で完了するライブラリー調製ワークフロー
  • イルミナおよびサーモフィッシャーシークエンサーに対応

Product Details

QIAseq Targeted RNA Panelsは、RNAseq による定量的遺伝子発現プロファイリングが可能なプライマーセットおよびライブラリー調製試薬です。分子バーコード技術を2段階PCR ベースの増幅ステップに組み込むことにより、バイアスを最小限に抑えた正確で定量的なRNA シークエンシングを実現します。また、ウェット検証済みのプライマーを用いており、安心してご使用いただけます。


  1.  Accuracy: Innovative digital sequencing (molecular barcode counting) eliminates PCR duplication and amplification bias to deliver the most accurate results (see figure  Unbiased and accurate gene quantification) .
  2.  Specificity: The unique combination of our proprietary primer design algorithm and rigorous testing of every primer assay guarantees high specificity and accurate results (see figure  Proprietary primer design delivers gene-specific amplicons – 97% specificity).
  3.  Uniformity: The QIAseq Targeted RNA Panel workflow has been optimized to deliver highly uniform sequencing results, to ensure sequencing capacity is utilized very efficiently. In fact, digital sequencing (molecular barcodes) entirely remove this variation in RNAseq counting (see figure  Unmatched uniformity – 97% of assays are within 20% of median molecular tag counts).
  4. Reproducibility: The QIASeq Targeted RNA Panel system demonstrates strong correlations across technical replicates, product lots and instruments with correlation coefficients averaging above >0.99, to ensure reliable detection of differences in expression between biological samples
  5.  Sensitivity: Digital RNA sequencing system is optimized to deliver highly reliable quantification down to ~100 copies of an RNA target in 25 ng total RNA (see figure  Positive results with as little as 0.2 copies of RNA per cell).
  6.  Flexibility: QIAseq panels combine the power of NGS with the accuracy of qPCR to allow multiplexing of several samples per NGS while delivering cost-effective results (see figure  Simple procedure).

See figures


  1. Traditional RNA sequencing methods suffer from PCR duplication and amplification bias, resulting in inaccurate gene expression analysis. By introducing molecular barcodes before any amplification takes place, QIAseq Targeted RNA Panels are able to eliminate this issue to deliver  accurate and digital quantification of genes (see figure  Unbiased and accurate gene quantification).
  2. A unique feature of the QIAseq Targeted RNA Panels is the set of built-in control assays. The gDNA assays control for any gDNA contamination in the RNA sample to ensure reproducible results. The housekeeping gene (HKG) assays are used to normalize data, thereby making sample-to-sample and run-to-run comparisons possible.


See figures


  • The QIAseq Targeted RNA Panels workflow begins with converting total RNA into cDNA (see figure Simple procedure). The workflow requires minimal RNA input: as little as 25 ng total RNA can be used. No enrichment or depletion steps are necessary. The molecular barcoding step makes use of molecularly barcoded gene-specific primer (GSP1) in a multiplex primer panel (targeting 12-1000 genes) and an input of 20ng of cDNA equivalent (cDNA made from 20 ng of total RNA). After the barcoding step, the uniquely tagged cDNA is purified over beads to remove residual primers, and a PCR is set up with a second pool of gene-specific adapter primers (GSP2) and the RS2 primer, which primes off of a common tag on the GSP1 primers. This reaction insures that intended targets are enriched sufficiently to be represented in the final library. The number of cycles is kept to a minimum to keep PCR-induced variations in amplification to a low level (any variations are easily corrected and accounted for with the molecular barcodes). Another quick cleanup with beads is performed, and a universal PCR is run with RS2 and FS2 primers, which also adds sample-indexing barcodes to each sample. A final cleanup with beads is performed and the library is complete, and ready for quantification and sequencing.
  • An integral component of the QIAseq Targeted RNA Panels is data analysis and insight. Data analysis modules have been developed that are comprehensive, yet easy to use. Using these modules require no bioinformatics expertise. Starting with raw reads directly off the sequencer, the QIAseq targeted RNA data analysis tools atQIAGEN’s GeneGlobe portal, provide you with gene counts and fold changes, as well as links for pathway analysis.
See figures


  • Gene expression profiling
  • Biomarker research
  • Confirmation of whole transcriptome sequencing data
  • Confirmation of microarray data

Supporting data and figures


MSDS (2)
Download Safety Data Sheets for QIAGEN product components.
Download Safety Data Sheets for QIAGEN product components.
サイエンティフィック・ポスター (1)
Poster for download
パンフレット (3)
State-of-the-art technologies to fast-track and streamline NGS workflows
キットハンドブック (1)
Certificates of Analysis (1)
Brochures & Guides (3)
State-of-the-art technologies to fast-track and streamline NGS workflows
Kit Handbooks (1)
Scientific Posters (1)
Poster for download


Assessment of mitochondrial function following short- and long-term exposure of human bronchial epithelial cells to total particulate matter from a candidate modified-risk tobacco product and reference cigarettes.
Malinska D; Szymański J; Patalas-Krawczyk P; Michalska B; Wojtala A; Prill M; Partyka M; Drabik K; Walczak J; Sewer A; Johne S; Luettich K; Peitsch MC; Hoeng J; Duszyński J; Szczepanowska J; van der Toorn M; Wieckowski MR;
Food Chem Toxicol; 2018; 115 :1-12 2018 Feb 13 PMID:29448087
A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells.
Kaur S; Elkahloun AG; Singh SP; Arakelyan A; Roberts DD;
J Cell Commun Signal; 2017; 12 (1):157-170 2017 Nov 29 PMID:29188480
An Atlas of Human Regulatory T Helper-like Cells Reveals Features of Th2-like Tregs that Support a Tumorigenic Environment.
Halim L; Romano M; McGregor R; Correa I; Pavlidis P; Grageda N; Hoong SJ; Yuksel M; Jassem W; Hannen RF; Ong M; Mckinney O; Hayee B; Karagiannis SN; Powell N; Lechler RI; Nova-Lamperti E; Lombardi G;
Cell Rep; 2017; 20 (3):757-770 2017 Jul 18 PMID:28723576
Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia.
Delker DA; Wood AC; Snow AK; Samadder NJ; Samowitz WS; Affolter KE; Boucher KM; Pappas LM; Stijleman IJ; Kanth P; Byrne KR; Burt RW; Bernard PS; Neklason DW;
Cancer Prev Res (Phila); 2017; 11 (1):4-15 2017 Nov 6 PMID:29109117
A Role for Iodide and Thyroglobulin in Modulating the Function of Human Immune Cells.
Bilal MY; Dambaeva S; Kwak-Kim J; Gilman-Sachs A; Beaman KD;
Front Immunol; 2017; 8 :1573 2017 Nov 15 PMID:29187856